Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Levodopa-carbidopa intestinal gel (LCIG) treatment in routine care of patients with advanced Parkinson's disease: An open-label prospective observational study of effectiveness, tolerability and healthcare costs.
Pålhagen SE, Sydow O, Johansson A, Nyholm D, Holmberg B, Widner H, Dizdar N, Linder J, Hauge T, Jansson R, Bergmann L, Kjellander S, Marshall TS. Pålhagen SE, et al. Among authors: dizdar n. Parkinsonism Relat Disord. 2016 Aug;29:17-23. doi: 10.1016/j.parkreldis.2016.06.002. Epub 2016 Jun 4. Parkinsonism Relat Disord. 2016. PMID: 27318707 Free article.
Initiation of Levodopa-Carbidopa Intestinal Gel Infusion Using Telemedicine (Video Communication System) Facilitates Efficient and Well-Accepted Home Titration in Patients with Advanced Parkinson's Disease.
Willows T, Dizdar N, Nyholm D, Widner H, Grenholm P, Schmiauke U, Urbom A, Groth K, Larsson J, Permert J, Kjellander S. Willows T, et al. Among authors: dizdar n. J Parkinsons Dis. 2017;7(4):719-728. doi: 10.3233/JPD-161048. J Parkinsons Dis. 2017. PMID: 28984615 Free PMC article.
Treatment of Parkinson's disease with NADH.
Dizdar N, Kågedal B, Lindvall B. Dizdar N, et al. Acta Neurol Scand. 1994 Nov;90(5):345-7. doi: 10.1111/j.1600-0404.1994.tb02735.x. Acta Neurol Scand. 1994. PMID: 7887134 Clinical Trial.
A Phase 2a Trial Investigating the Safety and Tolerability of the Novel Cortical Enhancer IRL752 in Parkinson's Disease Dementia.
Svenningsson P, Odin P, Dizdar N, Johansson A, Grigoriou S, Tsitsi P, Wictorin K, Bergquist F, Nyholm D, Rinne J, Hansson F, Sonesson C, Tedroff J; IRL752 Collaborators. Svenningsson P, et al. Among authors: dizdar n. Mov Disord. 2020 Jun;35(6):1046-1054. doi: 10.1002/mds.28020. Epub 2020 Mar 21. Mov Disord. 2020. PMID: 32198802 Clinical Trial.
S100B polymorphisms are associated with age of onset of Parkinson's disease.
Fardell C, Zettergren A, Ran C, Carmine Belin A, Ekman A, Sydow O, Bäckman L, Holmberg B, Dizdar N, Söderkvist P, Nissbrandt H. Fardell C, et al. Among authors: dizdar n. BMC Med Genet. 2018 Mar 12;19(1):42. doi: 10.1186/s12881-018-0547-3. BMC Med Genet. 2018. PMID: 29529989 Free PMC article.
51 results